DocMorris Forecast, price target & analysts
DocMorris Target price 2026 - Analyst rating & recommendation
DocMorris Classifications & Recommendation
DocMorris Price Target
| Target Price | CHF11.73 |
| Price | CHF12.56 |
| Deviation |
6.61%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target DocMorris 2027 .
The average DocMorris target price is CHF11.73.
This is
6.61%
register free of charge
CHF14.18
12.86%
register free of charge
CHF10.25
18.38%
register free of charge
|
|
| A rating was issued by 13 analysts: 7 Analysts recommend DocMorris to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2027 of
6.61%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 1.12 | 1.28 |
| 10.56% | 14.01% | |
| EBITDA Margin | -4.76% | -1.27% |
| 15.84% | 73.31% | |
| Net Margin | -11.95% | -6.81% |
| 25.00% | 43.02% |
9 Analysts have issued a sales forecast DocMorris 2026 . The average DocMorris sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an DocMorris EBITDA forecast 2026. The average DocMorris EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 DocMorris Analysts have issued a net profit forecast 2026. The average DocMorris net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -3.47 | -1.81 |
| 14.53% | 47.84% | |
| P/E | negative | |
| EV/Sales | 0.70 |
9 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris EPS is
This results in the following potential growth metrics and future valuations:
Current DocMorris Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| RESEARCH PARTNERS AG |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 24 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
RESEARCH PARTNERS AG:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 15 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 24 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
